Reporting of Outcomes and Outcome Measures in Studies of Interventions to Prevent and/or Treat Delirium in the Critically Ill: A Systematic Review.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 25 3 2020
pubmed: 25 3 2020
medline: 10 2 2021
Statut: ppublish

Résumé

To inform development of a core outcome set, we evaluated the scope and variability of outcomes, definitions, measures, and measurement time-points in published clinical trials of pharmacologic or nonpharmacologic interventions, including quality improvement projects, to prevent and/or treat delirium in the critically ill. We searched electronic databases, systematic review repositories, and trial registries (1980 to March 2019). We included randomized, quasi-randomized, and nonrandomized intervention studies of pharmacologic and nonpharmacologic interventions. We extracted data on study characteristics, verbatim descriptions of study outcomes, and measurement characteristics. We assessed quality of outcome reporting using the Management of Otitis Media with Effusion in Children with Cleft Palate study scoring system; risk of bias and study quality using the Cochrane tool and Scottish Intercollegiate Guidelines Network checklists. We categorized reported outcomes using Core Outcome Measures in Effectiveness Trials taxonomy. From 195 studies (1/195 pediatric) recruiting 74,632 participants and reporting a mean (SD) of 10 (6.2) outcome domains, we identified 12 delirium-specific outcome domains. Delirium incidence (147, 75% of studies), duration (67, 34%), and antipsychotic use (42, 22%) were most commonly reported. We identified a further 94 non-delirium-specific outcome domains within 19 Core Outcome Measures in Effectiveness Trials taxonomy categories. For both delirium-specific and nonspecific outcome domains, we found multiple outcomes in domains due to differing descriptions and time-points. The Confusion Assessment Method-ICU with Richmond Agitation-Sedation Scale to assess sedation was the most common measure used to ascertain delirium (51, 35%). Measurement generally began at randomization or ICU admission, and lasted from 1 to 30 days, ICU/hospital discharge. Frequency of measurement was highly variable with daily measurement and greater than daily measurement reported for 36% and 37% of studies, respectively. We identified substantial heterogeneity and multiplicity of outcome selection and measurement in published studies. These data will inform the consensus building stage of a core outcome set to inform delirium research in the critically ill.

Identifiants

pubmed: 32205622
doi: 10.1097/CCM.0000000000004238
pii: 00003246-202004000-00034
doi:

Substances chimiques

Antipsychotic Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e316-e324

Subventions

Organisme : Medical Research Council
ID : G0901530
Pays : United Kingdom
Organisme : Department of Health
ID : PB-PG-0610-22068
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R24 AG054259
Pays : United States
Organisme : CIHR
Pays : Canada

Auteurs

Louise Rose (L)

Department of Critical Care Medicine, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, United Kingdom.

Meera Agar (M)

Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia.

Lisa Burry (L)

Department of Pharmacy, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.

Noll Campbell (N)

College of Pharmacy, Indiana University-Purdue University, Indianapolis, IN.

Mike Clarke (M)

School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland.

Jacques Lee (J)

Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

John Marshall (J)

St Michael's Hospital and Li Ka Shing Research Institute, Toronto, ON, Canada.

Najma Siddiqi (N)

School of Medicine, York University, York, United Kingdom.

Valerie Page (V)

Intensive Care Unit, Watford General Hospital, Watford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH